Apr 10, 2017 at 16:28 | Source: CNBC-TV18
As global drug makers are exiting low priority brands, their Indian counterparts are lapping up the opportunity buying established products at perhaps low valuations.
Apr 01, 2017 at 18:13 | Source: Moneycontrol.com
Intas said it is undertaking a detailed analysis on reports of inflammation and has advised doctors to avoid using the product, meant to treat an age-related eye condition, from this specific batch.
Mar 31, 2017 at 19:18 | Source: Moneycontrol.com
This is to inform you that the board meeting of Directors to be held on May 23, 2017
Mar 23, 2017 at 15:58 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) for its Tobramycin Inhalation Solution, the Mumbai-based company said in a statement.
Mar 07, 2017 at 09:37 | Source: CNBC-TV18
In an interview to CNBC-TV18, Rajen Shah, Chief Investment Advisor at Tradebulls Group shared his readings and outlook on specific stocks and sectors.
Feb 10, 2017 at 16:28 | Source: CNBC-TV18
Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.
Feb 10, 2017 at 14:55 | Source: Moneycontrol.com
The 2016 Special 301 Report continued with the placement of India on the PWL despite noting several positives that have contributed to a better environment for the protection and enforcement of intellectual property rights in India.
Feb 10, 2017 at 09:46 | Source: PTI
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow, according to a press release issued by the incubator.
Feb 08, 2017 at 18:00 | Source: Moneycontrol.com
The drug makers much anticipated launch of key blood cancer treatment drug imatinib mesylate in US is facing the risk of further delay, as a partner which the company contracted to supply the drug has hit regulatory compliance hurdle.
Feb 07, 2017 at 22:14 | Source: CNBC-TV18
Shereen Bhan speaks with top bosses from the pharma sector along with KT Rama Rao, Minister of IT, Telangana at Bioasia 2017 to discuss way forward for pharma sector in making India healthier.